These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6213763)

  • 1. New sustained release dosage form of chlorhexidine for dental use. I. Development and kinetics of release.
    Friedman M; Golomb G
    J Periodontal Res; 1982 May; 17(3):323-8. PubMed ID: 6213763
    [No Abstract]   [Full Text] [Related]  

  • 2. A new degradable controlled release device for treatment of periodontal disease: in vitro release study.
    Steinberg D; Friedman M; Soskolne A; Sela MN
    J Periodontol; 1990 Jul; 61(7):393-8. PubMed ID: 2388137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New sustained release dosage form of chlorhexidine for dental use: use for plaque control in partial denture wearers.
    Hirschfeld Z; Friedman M; Golomb G; Ben-Yaacov D
    J Oral Rehabil; 1984 Sep; 11(5):477-82. PubMed ID: 6594487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of liquid crystalline structure on chlorhexidine diacetate release.
    Farkas E; Zelkó R; Németh Z; Pálinkás J; Marton S; Rácz I
    Int J Pharm; 2000 Jan; 193(2):239-45. PubMed ID: 10606788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New sustained release dosage form of chlorhexidine for dental use. II. Use in periodontal therapy.
    Soskolne A; Golomb G; Friedman M; Sela MN
    J Periodontal Res; 1983 May; 18(3):330-6. PubMed ID: 6225862
    [No Abstract]   [Full Text] [Related]  

  • 6. Plaque inhibition by sustained release of chlorhexidine from removable appliances.
    Friedman M; Harari D; Raz H; Golomb G; Brayer L
    J Dent Res; 1985 Nov; 64(11):1319-21. PubMed ID: 3867693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate.
    Huynh TT; Padois K; Sonvico F; Rossi A; Zani F; Pirot F; Doury J; Falson F
    Eur J Pharm Biopharm; 2010 Feb; 74(2):255-64. PubMed ID: 19909814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrolysis and dissolution behavior of a prolonged-release prodrug of theophylline: 7,7'-succinylditheophylline.
    Lee HK; Lambert H; Stella VJ; Wang D; Higuchi T
    J Pharm Sci; 1979 Mar; 68(3):288-95. PubMed ID: 34020
    [No Abstract]   [Full Text] [Related]  

  • 9. Local application of sustained-release delivery system of chlorhexidine in Down's syndrome population.
    Stabholz A; Shapira J; Shur D; Friedman M; Guberman R; Sela MN
    Clin Prev Dent; 1991; 13(5):9-14. PubMed ID: 1839722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration dependent aggregation properties of chlorhexidine salts.
    Zeng P; Zhang G; Rao A; Bowles W; Wiedmann TS
    Int J Pharm; 2009 Feb; 367(1-2):73-8. PubMed ID: 18926892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a latex foley catheter with sustained release of chlorhexidine.
    Mochizuki M; Umemura Y; Ozaki Y
    Trans Am Soc Artif Intern Organs; 1985; 31():289-92. PubMed ID: 3837458
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro evaluation of an anticholinergic agent in a timed-release solid dosage formulation.
    Gumtow RH; Beecher H; Hartnett D; Glogowski D
    J Pharm Sci; 1977 Dec; 66(12):1777-9. PubMed ID: 925949
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of a sustained release chlorhexidine varnish as treatment of oral necrobacillosis in Macropus spp.
    Bakal-Weiss M; Steinberg D; Friedman M; Gati I; Avni-Magen N; Kaufman E; Lavy E
    J Zoo Wildl Med; 2010 Jun; 41(2):371-3. PubMed ID: 20597238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of a prolonged-release tablet formulation of diclofenac sodium. Part 1: Using chitosan.
    Acartürk F
    Pharmazie; 1989 Aug; 44(8):547-9. PubMed ID: 2594826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of sustained release delivery of chlorhexidine for the maintenance of periodontal pockets: 2-year clinical trial.
    Stabholz A; Soskolne WA; Friedman M; Sela MN
    J Periodontol; 1991 Jul; 62(7):429-33. PubMed ID: 1920009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local chlorhexidine delivery using hydroxypropylcellulose (HPC) strips in the control of subgingival plaque. Microbiological and clinical observations].
    Kitamura S
    Nihon Shishubyo Gakkai Kaishi; 1984 Mar; 26(1):9-20. PubMed ID: 6381617
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of sustained-release chlorhexidine acetate on the human dental plaque flora.
    Schaeken MJ; De Haan P
    J Dent Res; 1989 Feb; 68(2):119-23. PubMed ID: 2918132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of chlorhexidine from UDMA-TEGDMA resin.
    Anusavice KJ; Zhang NZ; Shen C
    J Dent Res; 2006 Oct; 85(10):950-4. PubMed ID: 16998139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro studies of tizanidine controlled-release microcapsular matrices.
    Dashora K; Saraf S; Saraf S
    Pak J Pharm Sci; 2006 Jul; 19(3):177-81. PubMed ID: 16935822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Access to subgingival plaque by direct drug delivery].
    Noguchi T; Fukuda M; Tachibana T; Suzuki C; Kitamura S; Miyagawa M; Kobayashi M; Izumizawa K; Kinoshita S
    Nihon Shishubyo Gakkai Kaishi; 1983 Sep; 25(3):554-61. PubMed ID: 6582176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.